Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
27 March 2000Website:
http://www.edwards.comNext earnings report:
06 February 2025Last dividends:
N/ANext dividends:
N/APrice
after hours | Fri, 01 Nov 2024 23:58:03 GMTDividend
Analysts recommendations
Institutional Ownership
Included in screeners
EW Latest News
LOS ANGELES, CA / ACCESSWIRE / November 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.
Investors in Edwards Lifesciences Corporation who have lost money are urged to reach out to BFA Law before the legal deadline of December 13, 2024.
NEW YORK, Nov. 1, 2024 /PRNewswire/ -- The Rosen Law Firm, a worldwide law firm focused on investor rights, is reminding buyers of Edwards Lifesciences Corporation (NYSE: EW) securities from February 6, 2024, to July 24, 2024, that the deadline to become a lead plaintiff is December 13, 2024. If you bought securities during this time, you might be eligible for compensation without having to pay any upfront fees or costs, thanks to a contingency fee agreement.
On November 1, 2024, Bleichmar Fonti & Auld LLP, a prominent securities law firm, announced that a lawsuit has been initiated against Edwards Lifesciences Corporation (NYSE:EW) and some of its top executives for possible breaches of federal securities laws. If you have invested in Edwards Lifesciences, you are invited to find more details by visiting https://www.bfalaw.com/cases-investigations/edwards-lifesciences-corporation.
NEW YORK, NY / ACCESSWIRE / November 1, 2024 / If you experienced a loss from your investment in Edwards Lifesciences Corporation (NYSE:EW) and are interested in possible recovery under federal securities laws, please click the link below for further details: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110404&wire=1 or reach out to Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / November 1, 2024 / If you experienced a loss from your investment in Edwards Lifesciences Corporation (NYSE:EW) and are interested in possible recovery under federal securities laws, please click the link below for further details: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110399&wire=1 or reach out to Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / November 1, 2024 / If you experienced a loss from your investment in Edwards Lifesciences Corporation (NYSE:EW) and are interested in possible recovery under federal securities laws, please click the link below for further details: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110391&wire=1 or reach out to Joseph E. Levi, Esq.
NEW YORK, Nov. 01, 2024 (GLOBE NEWSWIRE) -- This is an advertisement from a law firm. Bronstein, Gewirtz & Grossman, LLC, a well-known law firm in the country, informs investors that a class action lawsuit has been initiated against Edwards Lifesciences Corporation (“Edwards” or “the Company”) (NYSE: EW) and some of its executives.
NEW YORK, NY / ACCESSWIRE / November 1, 2024 / If you experienced a loss from your investment in Edwards Lifesciences Corporation (NYSE:EW) and are interested in possible recovery under federal securities laws, please click the link below for further details: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110386&wire=1 or reach out to Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / November 1, 2024 / If you experienced a loss from your investment in Edwards Lifesciences Corporation (NYSE:EW) and are interested in possible recovery under federal securities laws, please click the link below for further details: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110343&wire=1 or reach out to Joseph E. Levi, Esq.
What type of business is Edwards Lifesciences?
Edwards Lifesciences Corporation is an American company headquartered in Irvine, California, specializing in the production and distribution of medical equipment for monitoring structural heart diseases and intensive therapy. It was founded in 1958. It is the world's leading manufacturer of cardiovascular system valves and means for their replacement or repair. It is also a global leader in the field of hemodynamic monitoring systems used to measure the cardiovascular function of patients. The company's products and solutions can be divided into several groups: transcatheter therapy, surgical therapy, intensive therapy.
What sector is Edwards Lifesciences in?
Edwards Lifesciences is in the Healthcare sector
What industry is Edwards Lifesciences in?
Edwards Lifesciences is in the Medical Devices industry
What country is Edwards Lifesciences from?
Edwards Lifesciences is headquartered in United States
When did Edwards Lifesciences go public?
Edwards Lifesciences initial public offering (IPO) was on 27 March 2000
What is Edwards Lifesciences website?
https://www.edwards.com
Is Edwards Lifesciences in the S&P 500?
Yes, Edwards Lifesciences is included in the S&P 500 index
Is Edwards Lifesciences in the NASDAQ 100?
No, Edwards Lifesciences is not included in the NASDAQ 100 index
Is Edwards Lifesciences in the Dow Jones?
No, Edwards Lifesciences is not included in the Dow Jones index
When was Edwards Lifesciences the previous earnings report?
No data
When does Edwards Lifesciences earnings report?
The next expected earnings date for Edwards Lifesciences is 06 February 2025